METTL14,,

Xin Liu1,2,3, Heng Liu1,2,3, Yuan Lin1,2,3

  • 1State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Department of Pharmacology, College of Pharmacy, and Department of Cardiology, The Second Affiliated Hospital, Harbin Medical University, 157 Baojian Road, Harbin 150081, China.

European heart journal
|August 4, 2025
PubMed
概括

甲基转移酶样蛋白14 (METTL14) 通过通过METTL14/Toll样受体4 (TLR4) 途径促进炎症,驱动血管衰老. 抑制METTL14可以治疗血管衰老和相关疾病.